🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2026

Annual patent cliff calendar for 2026 — US pharmaceutical patents by expiration date.

Patents
360

Quick answer

360 indexed pharmaceutical patents have expiration dates in 2026. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7153866

    Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7153882

    Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7153947

    Ixodes salivary anticomplement protein

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7153967

    Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7153972

    Benzimidazole derivatives, their production and use

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7153509

    Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope

    The Regents of the University of California · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7153677

    Hyaluronan synthase gene and uses thereof

    The Board of Regents of the University of Oklahoma · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7153519

    Implantable substrate coated with a macromer having free radical polymerizable substituents

    The Board of Regents of the University of Texas System · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7153514

    Use of botulinum toxin therapy for prostatic hyperplasia and related disorders

    The Regents of the University of Colorado · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7153683

    TAO protein kinase polypeptides and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7153838

    Pharmacologically acceptable solvent vehicles

    The Board of Regents of the University of Texas System · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7153936

    Semaphorin gene family

    The Regents of the University of California · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7153880

    Substituted diphenyl heterocycles useful for treating HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7157476

    Aminofurazan compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7157584

    Benzimidazole derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7157082

    Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase

    THE ARIZONA BOARD OF REGENTS · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7157259

    Murine lecithin-cholesterol acyltransferase protein

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7157092

    Acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same

    OM PHARMA · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7157435

    Methods for modulation of the effects of aging on the primate brain

    The Regents of the University of California · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7157439

    HoxD3, HoxA3, and HoxB3 compositions and methods for improved wound healing

    The Regents of the University of California · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7157473

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7157495

    Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7157554

    Glycopeptide carboxy-saccharide derivatives

    Theravance, Inc. · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7157546

    Water-soluble polymer alkanals

    Nektar Therapeutics AL, Corporation · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2026?

360 published patents in our USPTO index have expiration dates falling in calendar year 2026.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.